Skip to main content
Premium Trial:

Request an Annual Quote

Grace Bio-Labs Inks Deal for Avantra's Path Slides

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Grace Bio-Labs today announced a manufacturing and distribution deal for Avantra Biosciences' Path protein microarray ultra-thin non-porous nitrocellulose slides.

The Path Slides provide many of the benefits of nitrocellulose "in a thin film that allows very low background fluorescence and excellent signal-to-noise ratio," Grace Bio-Labs said in a statement. The Bend, Ore., firm also offers its own Oncyte porous nitrocellulose thin film slides, which it says offers the highest binding capacity for protein applications.

Grace Bio-Labs will sell the Path slides directly from its website and through a distribution agreement with Sigma-Aldrich, which also distributes other Grace Bio-Labs products.

Financial and other terms of the deal were not released.

Grace Bio-Labs develops and manufactures products for protein and cell analysis research.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more